Item 8.01. Other Events.

On June 22, 2022, Vaxart, Inc. (the "Company") held a live question-and-answer session via webcast with investors to provide an overview of the Company's oral vaccine programs and to discuss the proposals being submitted at the Company's annual meeting of stockholders, which is now being held on July 6, 2022, following its adjournment.

A copy of the Company's investor questions and answers is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.




Item 9.01.     Financial Statements and Exhibits.

(d) Exhibits.

99.1 Copy of investor questions and answers .

104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses